✦ LIBER ✦

FDA and EMA assess the pancreatic safety of incretin-based drugs

Book ID: 125390419
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 199 KB
Volume: 1492
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-014-9307-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incretin-based drugs: risk of pancreatit

Incretin-based drugs: risk of pancreatitis assessed

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Incretin-based drugs and risk of pancrea

Incretin-based drugs and risk of pancreatitis: latest data

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB

Licensing of antirheumatic drugs: Are th

Licensing of antirheumatic drugs: Are the EMA and FDA on the same page?

✍ Bannwarth, Bernard; Berdaï, Driss; Kostine, Marie 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The Role of DSM in the EMA and FDA Autho

The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs

✍ Meyers, O.I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

A Comparison Of New Drugs Approved By Th

A Comparison Of New Drugs Approved By The EMA and the FDA in 2006–2011

✍ Alshehri, N.; Seoane-Vazquez, E.; Rodriguez-Monguio, R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Incretin-Based Drugs and the Risk of Con

Incretin-Based Drugs and the Risk of Congestive Heart Failure

✍ Yu, Oriana Hoi Yun; Filion, Kristian B.; Azoulay, Laurent; Patenaude, Valerie; M 📂 Article 📅 2014 🏛 American Diabetes Association 🌐 English ⚖ 931 KB